5632-81-5 Usage
General Description
2-Chloro-3,5-diaminopyridine is a chemical compound with the molecular formula C5H6ClN3. It is a derivative of the amino acid lysine and is used in the synthesis of pharmaceuticals and agrochemicals. 2-chloro-3,5-diaminopyridine has potential applications as an intermediate in the preparation of new therapeutic agents, including antiviral and anticancer drugs. It is also used as a building block in the development of dyes and pigments, as well as in the production of polymers and specialty chemicals. Additionally, 2-chloro-3,5-diaminopyridine has been studied for its potential use as a corrosion inhibitor and as a component in materials for electronic applications.
Check Digit Verification of cas no
The CAS Registry Mumber 5632-81-5 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 5,6,3 and 2 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 5632-81:
(6*5)+(5*6)+(4*3)+(3*2)+(2*8)+(1*1)=95
95 % 10 = 5
So 5632-81-5 is a valid CAS Registry Number.
InChI:InChI=1/C5H6ClN3/c6-5-4(8)1-3(7)2-9-5/h1-2H,7-8H2
5632-81-5Relevant articles and documents
BRD4-JAK2 INHIBITORS
-
Page/Page column 141, (2020/03/29)
Disclosed herein are compounds that are inhibitors of BDR4 and their use in the treatment of cancer. Methods of screening for selective inhibitors of BDR4 are also disclosed. In certain aspects, disclosed are compounds of Formula I through IV.
A modular approach to synthetic RNA binders of the hepatitis C virus internal ribosome entry site
Carnevali, Maia,Parsons, Jerod,Wyles, David L.,Hermann, Thomas
scheme or table, p. 1364-1367+1315 (2011/04/24)
(Figure Presented) DAPper ligands: The 3,5-diaminopiperidine (DAP) heterocycle has been developed as a structural mimetic of the RNA-recognizing pharmacophore of the 2-DOS scaffold. Here we describe the synthesis of novel modular DAP ligands that bind to a conformational target in the internal ribosome entry site RNA of the hepatitis C virus.
CYANOGUANIDINES AS K-CHANNEL BLOCKERS
-
, (2008/06/13)
-
